We've found
3,769
archived clinical trials in
Migraine Headaches
We've found
3,769
archived clinical trials in
Migraine Headaches
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
Updated: 12/31/1969
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
Updated: 12/31/1969
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
Updated: 12/31/1969
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
Updated: 12/31/1969
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
Updated: 12/31/1969
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
Updated: 12/31/1969
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
Updated: 12/31/1969
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
Updated: 12/31/1969
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
Updated: 12/31/1969
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
Updated: 12/31/1969
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Updated: 12/31/1969
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pilot Study of Creative Arts Interventions for Neurology Inpatients
Updated: 12/31/1969
A Pilot Study of Creative Arts Interventions for Neurology Inpatients in the Epilepsy Monitoring Unit and the Headache Service
Status: Enrolling
Updated: 12/31/1969
A Pilot Study of Creative Arts Interventions for Neurology Inpatients
Updated: 12/31/1969
A Pilot Study of Creative Arts Interventions for Neurology Inpatients in the Epilepsy Monitoring Unit and the Headache Service
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prospective ED Headache Cohort Study
Updated: 12/31/1969
Predicting Poor Pain and Functional Outcomes After Discharge From the Emergency Department With a Primary Headache
Status: Enrolling
Updated: 12/31/1969
Prospective ED Headache Cohort Study
Updated: 12/31/1969
Predicting Poor Pain and Functional Outcomes After Discharge From the Emergency Department With a Primary Headache
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparing Naproxen to Sumatriptan for Emergency Headache Patients
Updated: 12/31/1969
A Randomized Clinical Trial to Compare Naproxen and Sumatriptan for Headache Patients Discharged From the Emergency Department (ED)
Status: Enrolling
Updated: 12/31/1969
Comparing Naproxen to Sumatriptan for Emergency Headache Patients
Updated: 12/31/1969
A Randomized Clinical Trial to Compare Naproxen and Sumatriptan for Headache Patients Discharged From the Emergency Department (ED)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparing Naproxen to Sumatriptan for Emergency Headache Patients
Updated: 12/31/1969
A Randomized Clinical Trial to Compare Naproxen and Sumatriptan for Headache Patients Discharged From the Emergency Department (ED)
Status: Enrolling
Updated: 12/31/1969
Comparing Naproxen to Sumatriptan for Emergency Headache Patients
Updated: 12/31/1969
A Randomized Clinical Trial to Compare Naproxen and Sumatriptan for Headache Patients Discharged From the Emergency Department (ED)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Metoclopramide for Migraine: A Dose Finding Study
Updated: 12/31/1969
Metoclopramide for Acute Migraine: A Dose Finding Study
Status: Enrolling
Updated: 12/31/1969
Metoclopramide for Migraine: A Dose Finding Study
Updated: 12/31/1969
Metoclopramide for Acute Migraine: A Dose Finding Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Mindfulness and Migraine Research Study
Updated: 12/31/1969
Mindfulness and Migraine: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Mindfulness and Migraine Research Study
Updated: 12/31/1969
Mindfulness and Migraine: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine
Updated: 12/31/1969
Prospective, Randomized, Placebo-controlled, Phase 2 Study of 4-aminopyridine, Atenolol, or Placebo in the Treatment of Patients With Vestibular Migraine
Status: Enrolling
Updated: 12/31/1969
4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine
Updated: 12/31/1969
Prospective, Randomized, Placebo-controlled, Phase 2 Study of 4-aminopyridine, Atenolol, or Placebo in the Treatment of Patients With Vestibular Migraine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Updated: 12/31/1969
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials